Search details
1.
Targeting RARA overexpression with tamibarotene, a potent and selective RARα agonist, is a novel approach in AML.
Blood Adv
; 7(9): 1858-1870, 2023 05 09.
Article
in English
| MEDLINE | ID: mdl-36477975
2.
CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial.
Nat Med
; 29(11): 2844-2853, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37872225
Results
1 -
2
de 2
1
Next >
>>